Form 4: PAVmed Director Debra White Granted 150,000 Restricted Shares

PAVmed Inc. Director Debra White received a grant of 150,000 restricted common shares, vesting in May 2028, under the company's long-term incentive plan.

Summary

• Debra White, a Director of PAVmed Inc. (PAVM), was granted 150,000 shares of common stock.
• The transaction occurred on September 30, 2025.
• These shares are restricted stock granted under the issuer's Sixth Amended and Restated 2014 Long-Term Incentive Equity Plan.
• The restricted stock has a single vesting date of May 20, 2028.
• The grant price for these shares was $0.
• Following this transaction, Debra White beneficially owns 215,000 shares of common stock.
• The restricted stock is subject to forfeiture if the requisite service period is not completed.

Sentiment

Score: 7

Explanation: The grant of restricted stock to a director is generally a positive event, signaling alignment of interests and long-term commitment. It is a routine compensation practice and not indicative of extraordinary performance or issues.

Positives

• The grant of restricted stock aligns the director's long-term interests with those of the shareholders.
• It serves as an incentive for the director to contribute to the company's sustained performance until the vesting date in May 2028.

Negatives

• The issuance of new shares, even restricted, can lead to minor dilution for existing shareholders, though this is a standard practice for executive compensation.

Risks

• The restricted stock is subject to forfeiture if the requisite service period is not completed by the vesting date of May 20, 2028.

Future Outlook

The restricted stock grant, with a vesting date in May 2028, indicates a long-term commitment from the director and aligns future performance incentives with shareholder value creation.

Industry Context

Restricted stock grants are a common form of equity compensation for directors and executives in publicly traded companies, designed to align their interests with long-term shareholder value and encourage retention.

Comparison to Industry Standards

• Restricted stock grants are a standard component of director compensation packages across various industries, including the medical technology sector where PAVmed operates.
• The use of a long-term incentive equity plan (Sixth Amended and Restated 2014 Long-Term Incentive Equity Plan) is consistent with corporate governance best practices for attracting and retaining qualified board members.

Corporate Governance

Stakeholder Impact

• Shareholders: Minor potential for dilution, but benefits from increased alignment of director's interests with long-term company performance.
• Director (Debra White): Receives equity compensation, incentivizing continued service and contribution to company growth.

Next Steps

• The restricted shares will vest on May 20, 2028, provided the requisite service period is completed.

Key Dates

Recommendation

This Form 4 filing details a routine equity compensation grant to a director, which is a standard corporate practice. It does not contain information that would materially alter the company's fundamental valuation or operational outlook, thus a 'hold' recommendation is appropriate as it does not present a new catalyst for significant price movement.

Keywords

PAVmed, PAVM, Form 4, Insider Transaction, Restricted Stock, Equity Grant, Director Compensation, Long-Term Incentive Plan